Multiple Myeloma and Bisphosphonate-Related Osteonecrosis of the Mandible Associated with Dental Implants
Multiple myeloma (MM) is a malignant plasma cell disorder and more than 30% of patients with this pathology develop osteolytic lesions in the jaw. Either pamidronate or zoledronic acid is recommended in patients with MM who have one or more lytic lesions. However, bisphosphonate-related osteonecrosi...
Saved in:
Main Authors: | Luis Junquera, Lorena Gallego, Alejandro Pelaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Dentistry |
Online Access: | http://dx.doi.org/10.1155/2011/568246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
by: Eder Alberto Sigua-Rodriguez, et al.
Published: (2014-01-01) -
Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
by: Paolo Vescovi, et al.
Published: (2014-01-01) -
Is Bisphosphonate-Related Osteonecrosis of the Jaw an Infection? A Histological and Microbiological Ten-Year Summary
by: A. M. Hinson, et al.
Published: (2014-01-01) -
Imaging Findings of Bisphosphonate-Related Osteonecrosis of the Jaws: A Critical Review of the Quantitative Studies
by: André Ferreira Leite, et al.
Published: (2014-01-01) -
A Case of Bisphosphonate-Related Osteonecrosis of the Jaw in a Patient with Subpontic Osseous Hyperplasia
by: Chiaki Tsuji, et al.
Published: (2017-01-01)